Recurrence rates in primary spontaneous pneumothorax:A systematic review and meta-analysis by Walker, Steven P. et al.
                          Walker, S. P., Bibby, A. C., Halford, P., Stadon, L., White, P., &
Maskell, N. A. (2018). Recurrence rates in primary spontaneous
pneumothorax: A systematic review and meta-analysis. European





Link to published version (if available):
10.1183/13993003.00864-2018
Link to publication record in Explore Bristol Research
PDF-document
This is the accepted author manuscript (AAM). The final published version (version of record) is available online
via ERS at 10.1183/13993003.00864-2018 . Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the
published version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/
 
Page 1 of 10 
 
Recurrence rates in primary spontaneous pneumothorax: a systematic review and meta-analysis 
 
Abstract 
Primary Spontaneous Pneumothorax (PSP) recurrence rates vary widely in the published literature, with limited data 
describing the factors that influence recurrence.  The aims of this systematic review were to determine an 
estimation of PSP recurrence rates and describe risk factors for recurrence. 
 
A systematic review was conducted of all studies reporting PSP recurrence. Electronic searches were performed to 
identify English language publications of randomised trials and observational studies.  The population was adults 
with PSP, who underwent conservative management, pleural aspiration or chest drainage. The outcome of interest 
was recurrence. Articles were screened, and data extracted from eligible studies by two reviewers. 
 
Of 3607 identified studies, 29 were eligible for inclusion, comprising 13,548 patients. Pooled 1-year and overall 
recurrence rates were 29.0%(95% CI 20.9% to 37.0%) and 32.1%(95% CI 27.0% to 37.2%) respectively. Female gender 
was associated with increased recurrence, OR 3.0(95% CI 1.24 to 7.41), whilst smoking cessation was associated with 
fourfold decrease in risk, OR 0.26(95% CI 0.10 to 0.63). I2 for random effects meta-analysis was 94%(p<0.0001) 
reflecting high heterogeneity between studies.   
 
  
This systematic review demonstrates a 32% PSP recurrence rate, with greatest risk in the first year.  Female gender 
was associated with higher risk, suggesting possible gender-specific pathophysiology. 
 
Introduction  
Primary spontaneous pneumothorax (PSP) is a disease of young people, with an annual incidence of 7.4 per 100,000 
in males and 1.2 per 100,000 in females(1). Current BTS guidelines advise that pneumothorax recurrence is an 
indication for surgery (whether second ipsilateral or first contralateral),(2) however the incidence of recurrence is 
unknown.  PSP recurrence rates are typically cited as between 16 and 52%, which makes counselling about future risk 
difficult and creates uncertainty regarding the optimal management(3).   If recurrence rates are genuinely as high as 
50%, an argument could be made for definitive surgical repair at an earlier stage.  If the true rate is closer to the lower 
estimate, however, waiting for a recurrent episode before considering surgery is appropriate.  
 
Unfortunately, there are no established factors that predict recurrence and consequently no method for risk-
stratifying patients. Female gender, low body weight, smoking and height in males have all been postulated as risk 
factors for recurrence (4-7). Certain radiographic features have also been suggested to confer additional risk, 
including bullae on CT and pleural thickening on chest radiograph(8-10).  Importantly, there is no consensus on 
which treatment offers the greatest reduction in risk of recurrence(11-14).  
 
This study aimed to systematically review, appraise and synthesise the existing literature to determine an accurate 
estimate of PSP recurrence rates and to describe risk factors associated with recurrence.  The primary research 
question was “what is the rate of recurrence of PSP in adults who have undergone medical management and what 
factors are associated with increased risk of recurrence?”. The secondary research question was “What patient 
factors increase recurrence risk?”. 
 
Materials and Methods 
Search Strategy and selection criteria  
A systematic review was conducted to identify English-language studies, including randomised trials, non-
randomised trials, and observational studies of more than 10 participants.  Review articles, editorials, conference 
abstracts and animal or in vitro studies were excluded.  The population of interest was adults (≥18 year of age) with 
PSP, although studies including adolescents of 11 years and older were included if they comprised less than 25% of 
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the study population or if recurrence data for adults could be extracted separately.  Studies that examined patients 
with first occurrence or subsequent occurrence were included. Secondary spontaneous pneumothorax, iatrogenic 
and traumatic pneumothoraces were excluded and mixed studies where PSP recurrence outcomes could not be 
differentiated from other types of pneumothorax (secondary spontaneous, iatrogenic, traumatic) were also 
excluded. Interventions and comparators included in the review were conservative management, needle aspiration 
(NA), intercostal drainage (ICD) and ambulatory management. Studies which only examined surgical, thoracoscopic 
or pleurodesis interventions were excluded, as were mixed studies where surgical and pleurodesis outcomes could 
not differentiated from non-surgical/pleurodesis outcomes.  The outcome of interest was recurrence (either 
ipsilateral or contralateral) at any time point. Studies that only documented contralateral recurrence rates were not 
eligible.  
 
The initial electronic search was performed on 18/1/18 within Medline (Epub Ahead of Print, In-Process & Other 
Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) <1946 to Janaury 2018) and EMBASE (1950 to 
January 2018). The full search strategy is shown in Appendix A, and included MeSH headings and keyword searches 
of “pneumothorax”, “recurrence” and “epidemiology”. Two authors (SW and PH) independently screened abstracts 
for eligibility and excluded studies that did not meet the inclusion criteria.  Discrepancies were resolved with 
discussion with third author (NAM).  Eligible studies were obtained in full-text format and reviewed independently 
by two reviewers (SH and PH).  The search was repeated on 22/2/18 to capture recently published studies.  
Data-analysis 
Data were extracted independently by two authors (SW and PH), using the data collection sheet shown in Appendix 
B. Name of study, type of study, sex, age, number of PSP cases, interventions, whether PSP cases were first or 
recurrent episode, 1-year; 2-year; and overall recurrence rates, and follow-up period were extracted from each 
study.  
 
The principal summary measure was overall recurrence rate for all included studies, described using basic 
descriptors (mean, 95% confidence intervals (CI)).  1-year and 2-year recurrence rates pooled for all studies that 
reported these outcomes.  Odd ratios for recurrence were calculated, where possible, for different interventions.  
Odds ratios were calculated for smokers vs non-smokers, males vs females, and BMI (greater/less than 20 kg/m2). 
Hazard ratios were extracted for males versus females where available.  In studies with mixed population (e.g. PSP 
and SSP, or adolescents and adults) only data pertaining to adults with PSP were extracted. If a study stated in its 
methodology that data relevant to the PICO criteria was collected but did not report it, the authors were contacted 
and asked to provide raw data.  
 
Separate meta-analyses were conducted to examine overall recurrence rates, and 1-year and 2-year recurrence 
rates. All studies that reported the outcome of interest were included in the meta-analyses.  Due to high anticipated 
heterogeneity between study populations and interventions, a random-effects model was used.  Heterogeneity was 
calculated using estimates of I2.  Pooled recurrence rates were calculated separately for clinical cohorts and 
epidemiological studies reporting data from the general population. Separate meta-analyses were performed for 
studies that reported recurrence stratified by gender, intervention, weight and smoking status to provide estimates 
of recurrence based on patient characteristics.  Random effects models were used for all these analyses due to high 
anticipated heterogeneity. Univariable meta-regression was used to assess whether study-level characteristics were 
associated with increased reported recurrence rates. Characteristics examined were type of study (RCT vs non-RCT), 
year of publication (before 2000, after 2000), PSP type (first or recurrent), sample size and follow-up period (greater 
or less than two years). All analyses were conducted in Stata MP Version 13.1. 
 
Randomised studies that met the inclusion criteria were assessed using the Cochrane risk of bias tool.  Bias was 
assessed over the following pre-specified domains: random sequence generation, concealment of allocation, 
blinding of participants and personnel, blinding of outcome assessment, completeness of outcome data, selective 
reporting and other potential sources of bias. Non-randomised studies that met the inclusion criteria were assessed 
using the Newcastle-Ottawa assessment tool over the following pre-specified domains: selection, comparability  and 
outcome (15).  Risk of bias was assessed independently by two reviewers (SW and AB). Differences of opinion were 
resolved by discussion or by involvement of a third party (NAM).   
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The review was registered prospectively on the PROSPERO database, registration number CRD42018089409.  Full 
methodological details are available at 
http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018089409). 
Role of funding source 
No external funding was received for this study. 
 
Results  
The search identified 3,607 publications, of which 29 were eligible for inclusion (Figure 1). Overall pooled recurrence 
rate was 32.1% (95% CI 27.0% to 37.2%) (Figure 2). 12 studies documented 1-year recurrence, with a pooled 
recurrence rate of 29.0% (95% CI 20.9% to 37.0%).  
 
 
A total of 13,548 patients were included in the studies, with a median sample size of 79(range 18 to 10,956). 85% 
were male. Study dates ranged from 1965 to 2017. Four randomised control trials (RCT) were included; one 
compared NA to ICD insertion, 2 compared pleurodesis with standard care and one compared conservative 
management to surgery.  Twenty-five observational studies were included: 21 retrospective, 3 prospective and one 
population-based epidemiological study.  Average follow-up time varied significantly between studies, with mean 
duration ranging from 3 to 96 months. A summary of included studies is provided in Table 1.  
 
There was considerable variation in reported recurrence rates, ranging from 8%  to 74% (8). I2 for the random effects 
meta-analysis was 94% (p<0.0001).  This is likely to reflect the wide variety of patient populations, methodologies 
and interventions studied in the included papers. Assessment of risk of bias showed a high risk of bias in at least one 






Table 1: Study Characteristics 








Al-Alawi (16) 2009 Retrospective  208 Cx, ICD,   Nil Not stated 42MN 0.35 
Al-Mourgi (17) 2015 RCT 22 Cx, S Underwent 
surgery(19) 
1st 32.4MN 0.41 
Andersen (18) 1965 Retrospective  138 Cx, ICD SSP (48) 1st 71MN 0.16 
Casali (10) 2013 Retrospective  176 Cx, ICD,   Nil 1st 58 MN  0.46 
Chan (12) 2006 Retrospective  89 NA Nil 1st & recurrent 12  0.16 
Chen (19) 2008 Retrospective  18 ICD, S  Underwent surgery 
(34) 
1st 16MN 0.28 
Chen (20) 2008 Retrospective  33 NA, P Underwent 
pleurodesis (31) 
1st 13 MN 0.33 
Chen (21) 2013 RCT 108 ICD, P  Underwent 
pleurodesis (106) 
1st 12 0.49 
Ganesalingam (9) 2010 Retrospective  100 Cx, ICD Nil 1st  57MN 0.54 
Harvey (22) 1994 RCT 73 NA vs ICD Nil 1st  12  0.21 
Huang (23) 2017 Epidemiological 10956 Cx, ICD, S  Underwent surgery 
(8606) 
1st 60 to 
144  
0.24 
Karasaki (24) 2014 Retrospective  93 HVCD Underwent surgery 
(6) 
1st  12.5MD 0.34 
Kim (25) 2014 Retrospective  55 Cx, ICD, S  Underwent surgery  
(1) 
1st & recurrent  Unclear 0.16 




1st 3 0.08 
Lichter (27) 1974 Retrospective  24 Cx, ICD, S SSP (54) 1st 60-144  0.08 
 








1st & recurrent 29.1MN  0.32 
Martinez-Ramos(29) 2007 Retrospective  55 Cx, ICD Nil 1st 30.7MN 0.24 
Mehta (30) 2016 Retrospective  216 ICD Nil Not stated 14 MD  0.13 
Nishiuma (31) 2012 Retrospective  66 NA Failed NA (25) 1st & recurrent 12  0.36 
Noh (32) 2015 Retrospective  109 Cx, ICD, S ≤19 age (328) + 
Underwent surgery 
(76) 
Not stated   Unclear 0.48 
Noh (33) 2015 Retrospective  79 Cx, ICD Underwent surgery 
(183) 
Not stated Unclear 0.37 
Olesen (6) 2016 Prospective 
cohort study  
257 Cx, ICD Nil 1st 43.2MD  0.56 






1st 34 MN 0.23 
Primavesi (8) 2016 Retrospective  23 Cx, ICD, S Underwent surgery 
(33) 
1st 67 MD 0.74 
Sadikot (4) 1997 Retrospective  153 Cx, NA, ICD Nil 1st 54 MN 0.54 
Sayar (34) 2014 Prospective  154 ICD, S  Underwent surgery 
(27) 
Not stated   30.6 MN 0.14 
Schramel (35) 1996 Retrospective 
case control 
78 Cx, ICD, S  Underwent surgery 
(97) 
No follow up (34) 
1st & recurrent 96 MN 0.39 
Tan (5) 2017 Retrospective  97 Cx, NA, ICD, S Underwent surgery 
(176) 
1st 39 MD  0.56 
Tulay (36) 2015 Retrospective  68 ICD, S Underwent surgery 
(14) 
1st Unclear 0.27 
Cx: Conservative; HVCD: Heimlich valve chest drain; ICD: intercostal drain; MN: mean; MD: Median; NA: needle aspiration; NS: not stated; RCT: randomised control trial;        P: 




All studies included participants drawn from clinical populations, apart from one epidemiological study that analysed 
population-level data, from a national health research database in Taiwan(23).  This study of over 10,000 people, 
from a 13 year period, reported a slightly lower recurrence rate of 23.7% (95% CI 22.9 to 24.5), when surgically 
managed patients were excluded, compared with the pooled estimate for clinical studies (32.6%, 95% CI 26.1 to 
39.2). Recurrence rates were similar for randomised and non-randomised studies (35.4%, 95% CI 18.7 to 52.1 vs 





Factors associated with recurrence 
Eleven observational studies examined the association between gender and PSP recurrence(4-6, 8-10, 13, 16, 30, 32, 
33), with eight demonstrating increased recurrence rates in females (4-6, 9, 10, 13, 16, 32). Odd ratios could be 
determined from seven studies,(4, 5, 9, 13, 16, 30, 32) with random-effects meta-analysis demonstrating an OR of 
3.0 (95% CI 1.24 to 7.41, p=0.015) for female gender (see Figure 3). 4 studies reported hazard ratios for gender and 
meta-analysis yielded an estimated HR of 1.2 (95% CI 0.83 to 1.67, p=0.35) associated with being female (6, 8-10). 
Two studies, which demonstrated no difference between genders, were not included as either OR/HR could not be 
calculated(23), or only contralateral recurrences were examined in the gender subgroup analysis(33).  
 
 
Several different definitions and cut-offs were used to categorise smoking habits, weight and age, and therefore 
meta-analysis was not possible. Five observational studies examined the relationship between current smoking and 
recurrence (4-6, 9, 16) with only one  demonstrating a convincing association(16).  However, smoking cessation was 
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associated with reduced recurrence in 2 studies with OR of 0.22 (95% CI 0.05 to 0.97) and 0.28 (95% CI 0.10 to 0.89) 
respectively, with a pooled OR 0.26 (95% CI 0.10 to 0.63) (4, 16). 
 
Eight observational studies examined BMI or weight(4-6, 8, 10, 16, 32, 33), with 2 demonstrating a significant 
association between low BMI/weight and recurrence (5, 6).  Thirteen studies examined whether age correlated with 
recurrence, with ten studies finding no association (4-6, 9, 10, 13, 16, 25, 37, 38). Three studies demonstrated an 
increased risk with younger patients (23, 32, 33). 
Four studies examined CT radiographic scoring systems, based on number, size and distribution of air-filled lesions. 
(8, 10, 13, 29) The scores were not comparable, and produced conflicting results, which were not suitable for meta-
analysis. Two studies found an association between radiographic evidence of blebs and recurrence risk (8, 10) and 
two studies did not (13, 29). One study concluded that chest radiograph features such pleural thickening, 




Only one study compared recurrence in patients treated with needle aspiration versus chest drain(22) therefor 
precluding meta-analysis.  There were no RCTs comparing medical interventions with conservative management. Six 
non-randomised studies compared conservative management with either NA or ICD, with neither approach 





Univariable meta-regression did not demonstrate any significant association between PSP recurrence and study size, 
publication year, eligibility criteria, type of study, PSP type (first or recurrent) or follow up period (see Table 2).  
There was considerable unexplained residual heterogeneity even after adjusting for the different study 
characteristics.  
 
   Table 2: Univariable meta-regression of study characteristics 
  N Studies Pooled recurrence 




Study sample size  
<100 18 28.8 (21.7, 36.0)  0.234 94.05% 
>100 11 37.0 (28.4, 46.6)   
  
Publication year 
Before 2000 6 26.3 (11.5, 41.1) 0.324 94.05% 
After 2000 23 33.6(27.8, 39.4)   
  
Pneumothorax type 
1st pneumothorax 18 35.7 (27.9, 43.5) 0.273 94.02% 
1st & recurrent pneumothorax 6 23.4 (16.7, 30.1) 
  
Not stated 5 29.4 (17.0, 41.8)   
Follow-up period 
<24 months 10 26.5 (17.7, 35.2)    0.303 93.84% 
>24months  15 35.9 (27.9, 43.9)   
  
Not stated 4 31.9 (18.4, 45.4)   
Type of study 
Non-randomised 25 31.7 (26.3, 37.1) 0.729 93.91% 
Randomised  4 35.4 (18.7, 52.1)   
 




This is the first study to systematically review the literature on recurrence rates in adults with PSP who have been 
medically managed. Meta-analysis of data from 29 studies, totalling over 13,000 patients showed that 32% of 
patients will experience PSP recurrence, with most occurring within the first year.   
 
There was strong evidence that female gender was a risk factor for recurrence.  This is consistent with an 
epidemiological study that found an increased rate of pneumothorax recurrence in female patients, particularly in 
the age group 31-50 years of age, with re-hospitalisation rates of 54% compared with 46% in males (39). It is 
recognised that a proportion of pneumothoraces in women are secondary to underlying gender-specific 
pathophysiology, including lymphangioleiomyomatosis (LAM) and catamenial (endometriosis and non-endometriosis 
related) pneumothoraces.   Whilst catamenial pneumothoraces were historically thought to be a rare entity, with an 
early study attributing only characterising 1% of PSPs as such(40), a recent retrospective study demonstrated that up 
to 25% of women referred to surgery for recurrent pneumothoraces had evidence of thoracic endometriosis (41). 
The presence of these underlying conditions may explain the higher risk of recurrence seen in women.    
 
Low BMI is an established risk factors for the initial development of PSP (42, 43).  Whilst two studies (5, 6) 
demonstrated increased risk of recurrence with low weight and BMI respectively, differing classifications precluded  
meta-analysis. The hypothesis that PSP recurrence is linked with low body weight, either due to nutritional 
deficiencies affecting α1-antitrypsin levels or due to unbalanced physical development was supported by two papers 
(5, 6, 44-46). 
There is strong evidence supporting the link between smoking and developing a pneumothorax, with a clear dose-
response relationship (42, 47). However, only one study in this review demonstrated an association between 
smoking  and recurrence,(16) with several studies demonstrating a trend towards increased recurrence in non-
smokers (4-6, 9, 16, 48).  It has been suggested that there is a difference in aetiology between PSP in smokers and 
non-smokers, with ‘never smokers’ suffering from a genetic predisposition to pulmonary bullae, regardless of 
smoking habit. However, a more likely explanation is that the detrimental effect of smoking was obscured by the 
high base-line rates of cigarette smoking in the included studies and the heterogeneous classifications used to define 
smoking status.  The fact that smoking cessation reduced the risk of PSP recurrence adds further weight to the 
relationship between smoking and PSP.  Interestingly, this finding also suggests that smoking-related risk is 
reversible, at least in terms of early PSP recurrence (4, 16).   
 
 
There were insufficient number of studies included to determine if the choice of medical interventions (NA vs ICD) 
for PSP influenced recurrence rates. A recent meta-analysis comparing RCTS of NA versus ICD insertion found no 
difference of recurrence at one year between the interventions (49). There was no randomised data comparing 
conservative management to NA or ICD, but non-randomised data demonstrated no difference in recurrence 
between conservative management and intervention. It has been hypothesised that conservative management 
decreases the risk of recurrence, as slow re-expansion of the lung enables healing of the pleural defect (50, 51). 
However, conversely, it has been postulated that chest drain insertion may inflame the pleural surfaces, promoting 
pleural symphysis and preventing long-term recurrence (16). An RCT comparing standard and conservative 
management is currently recruiting and may offer clarification(51).  
 
The presence of bullae on imaging has been postulated as a predictor of recurrence, however, this theory was not 
supported by the findings of this review.  The lack of standardised radiographic scoring system may explain the 
conflicting results, although the hypothesis that rupture of bullae causes PSP is also debated (13, 45).  The modified 
dystrophic severity score (DSS), which assessed both blebs and bullae, appeared to be the most useful radiographic 
scoring system, however with a negative predictive value of over 90% but a positive predictive value of just 68%, it is 
of greatest value as a rule-out test (10).  The DSS has been used in one small subsequent study, but further 
prospective validation is required(8). 
 
The recurrence rates reported in the included studies varied widely, likely as a result of differences in study design 
and population, with no single identifiable  study characteristics which explained the variation.   
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Strengths and weaknesses of study 
This is the first systematic review of PSP recurrence rates, and it provides the most reliable estimate of overall 
recurrence to date, based on comprehensive evaluation of existing data.  Having an accurate estimate for recurrence 
will enable clinicians to provide better counselling for patients who have experienced their first PSP.   Sub-group 
analysis identified factors associated with higher recurrence rates, including female gender and continued cigarette 
smoking.  This finding will facilitate communication with patients and could be useful in guiding further treatment or 
investigations.  For example, if a patient is thought to be at high risk of recurrence, early referral for surgery may be 
considered.  Thus, this systematic review has clear clinical relevance and immediate potential for impact.  
 
The methodology of this review was rigorous, with dual, independent screening of abstracts, review of papers, data 
extraction and assessment of study quality.  Hence, we feel the result of this review is a reliable summation of the 
existing literature. Nonetheless, the review does have limitations.  There was significant heterogeneity between the 
included studies, and although a random effects meta-analysis model was used, this heterogeneity may have 
reduced the precision of the final estimated recurrence rate. Some of this heterogeneity is likely to be a result of 
differing study populations, and it should be acknowledged that for specific populations their true recurrence rate 
might appreciably differ from the estimates given.  The inclusion of studies with heterogeneous populations means 
the resultant estimate for recurrence rate can be considered representative of the population at large, at the 
expense, however, of more accurate estimates for specific populations. Whilst patients who were surgically 
managed or received pleurodesis were excluded from the meta-analysis on overall recurrence rates, this was not 
always possible in the subgroup analysis, which may confound these results.  This review is also limited by the quality 
of the data in the included studies.  RCT data was limited, and all included studies were at high risk of bias in at least 
one domain.  Non-randomised observational studies are at risk of selection bias and confounding by indication, and 
since many of the studies were also retrospective, there was a high risk of reporting and ascertainment bias.   
 
Conclusion 
In conclusion, this is the first systemic review of factors associated with PSP recurrence, combining rates from a broad 
range of sources to provide a pooled overall risk. It demonstrates that 32% of patients will develop a recurrence, with 
most of the risk in the first year. Recurrence rates did not differ based on the initial intervention for PSP.  Several 
factors were associated with a higher risk of recurrence, including female sex, lower BMI and radiological evidence of 
dystrophic lungs, whilst smoking cessation was associated with lower recurrence rates.  There was insufficient data to 
consider development of a risk stratification system.  
 
Funding statement 
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